InsidersTradesSigma
Explore the full record of transactions filed by Hidenobu Ishizaki, 股东. Director active across 1 company, notably ノイルイミューン・バイオテック株式会社. Cumulatively, 1 filings have been published. History available since 5 July 2023. The latest transaction was disclosed on 5 July 2023 (Holding update). Regulator: EDINET (Japan FSA). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Hidenobu Ishizaki is a major shareholder of Noil Immune Biotech Co., Ltd. As a shareholder, he influences the strategic direction and governance decisions of the company. Hidenobu Ishizaki is involved in the biotechnology sector, contributing to innovation and research. His commitment to operational excellence is essential for the success of his investments.